Novo Nordisk Pars is the third biggest Pharmaceutical importer in Iran in terms of turnover and one of the six Pharma companies that receive the highest amount of subsidized foreign currency from Iranian government. Zamaneh and the Danish media Danwatch have investigated Novo’s dealings in Iran to see whether ethical standards are being challenged.